Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Form PRE 14A: Preliminary proxy statement

Co-Diagnostics, Inc. Form PRE 14A: Preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-09-21: Form PRE 14A; Period of report 2026-09-21; Description PRE 14A; Document formpre14a.htm.
  • 2026-07-10: Form PRE 14A; Period of report 2026-07-09; Description PRE 14A; Document formpre14a.htm.
  • 2025-10-31: Form PRE 14A; Period of report 2025-10-31; Description PRE 14A; Document formpre14a.htm.
  • 2018-11-30: Form PRE 14A; Period of report 2018-11-30; Description Preliminary proxy statement; Document pre14a.htm.
FiledFormPeriod of reportDescriptionDocument
2026-09-21PRE 14A2026-09-21PRE 14Aformpre14a.htm
2026-07-10PRE 14A2026-07-09PRE 14Aformpre14a.htm
2025-10-31PRE 14A2025-10-31PRE 14Aformpre14a.htm
2018-11-30PRE 14A2018-11-30Preliminary proxy statementpre14a.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01